Vestal Point Capital »

GSK shares owned by Vestal Point Capital

Quarter-by-quarter ownership of GSK (GSK) shares owned by Vestal Point Capital from 13F filings

Historical chart of Vestal Point Capital investment in GSK

Tip: Access up to 7 years of quarterly data

All positions including GSK held by Vestal Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in GSK by Vestal Point Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $12M 300k 40.88

More positions owned by Vestal Point Capital

Insmed Com Par $.01 (INSM)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Cytokinetics Com New (CYTK)
Inari Medical Ord (NARI)
Arcellx Common Stock (ACLX)
Structure Therapeutics Sponsored Ads (GPCR)
Kalvista Pharmaceuticals (KALV)
Astria Therapeutics (ATXS)
Immatics NV SHS (IMTX)
Ultragenyx Pharmaceutical (RARE)
Ascendis Pharma A/S Sponsored Adr (ASND)
Soleno Therapeutics (SLNO)
Day One Biopharmaceuticals I (DAWN)
Savara (SVRA)
Agios Pharmaceuticals (AGIO)

View all positions for Vestal Point Capital

Top funds holding GSK

Dodge & Cox
JTC Employer Solutions Trustee
Fisher Investments
PRIMECAP Management Company
Morgan Stanley
T. Rowe Price Associates
Royal Bank of Canada
State Street Corporation
Mondrian Investment Partners
Goldman Sachs Group
Acadian Asset Management
Provident Trust
Arrowstreet Capital, Limited Partnership
Hsbc Holdings
Hotchkis and Wiley Capital Management

View all funds holding GSK